GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » EV-to-EBITDA

BDMD (Baird Medical Investment Holdings) EV-to-EBITDA : 4.27 (As of Dec. 16, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Baird Medical Investment Holdings's enterprise value is $69.47 Mil. Baird Medical Investment Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was $16.27 Mil. Therefore, Baird Medical Investment Holdings's EV-to-EBITDA for today is 4.27.

The historical rank and industry rank for Baird Medical Investment Holdings's EV-to-EBITDA or its related term are showing as below:

BDMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.27   Med: 7.32   Max: 11.63
Current: 4.27

During the past 3 years, the highest EV-to-EBITDA of Baird Medical Investment Holdings was 11.63. The lowest was 4.27. And the median was 7.32.

BDMD's EV-to-EBITDA is ranked better than
88.54% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 16.095 vs BDMD: 4.27

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-16), Baird Medical Investment Holdings's stock price is $1.55. Baird Medical Investment Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.354. Therefore, Baird Medical Investment Holdings's PE Ratio (TTM) for today is 4.38.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Baird Medical Investment Holdings EV-to-EBITDA Historical Data

The historical data trend for Baird Medical Investment Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings EV-to-EBITDA Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBITDA
- - -

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
EV-to-EBITDA - - - - -

Competitive Comparison of Baird Medical Investment Holdings's EV-to-EBITDA

For the Medical Devices subindustry, Baird Medical Investment Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baird Medical Investment Holdings's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Baird Medical Investment Holdings's EV-to-EBITDA falls into.



Baird Medical Investment Holdings EV-to-EBITDA Calculation

Baird Medical Investment Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=69.471/16.273
=4.27

Baird Medical Investment Holdings's current Enterprise Value is $69.47 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Baird Medical Investment Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was $16.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baird Medical Investment Holdings  (NAS:BDMD) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Baird Medical Investment Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.55/0.354
=4.38

Baird Medical Investment Holdings's share price for today is $1.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Baird Medical Investment Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.354.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Baird Medical Investment Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Baird Medical Investment Holdings Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN
Website
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.